What is Jasper Therapeutics Inc (JSPR) stock price today?

Jasper Therapeutics Inc (JSPR) currently trades at $0.94 per share. The stock has a market capitalization of $26.03M and a P/E ratio of —x.

Is JSPR stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Jasper Therapeutics Inc has a Smart Value Score of 22/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

JSPR

Jasper Therapeutics Inc

NASDAQ: JSPR · HEALTHCARE · BIOTECHNOLOGY

$0.94

+5.13% today

Updated 2026-04-30

Market cap

$26.03M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.95

Dividend yield

—

52W range

$1 – $7

Volume

0.4M

Market cap

$26.03M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.95

Dividend yield

—

52W range

$1 – $7

Volume

0.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$7.70

+722.65%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy3 Buy3 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-21.87M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$13.51M	$0.00	$0.00	$0.00	$0.00
Net income	$-37.69M	$-64.47M	$-71.27M	$-75.80M	$-9.10M
EPS	—	—	—	—	$-3.95
Free cash flow	$-46.43M	$-52.33M	$-63.15M	$-77.17M	$-21.87M
Profit margin	-278.92%	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
JSPR	$26.03M	22	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Jasper Therapeutics Inc trades at $0.94. Our Smart Value Score of 22/100 indicates the stock is weak.

Frequently asked questions

What is Jasper Therapeutics Inc's stock price?

Jasper Therapeutics Inc (JSPR) trades at $0.94.

Is Jasper Therapeutics Inc overvalued?

Smart Value Score 22/100 (Grade F, Strong Sell).

What is the price target of Jasper Therapeutics Inc (JSPR)?

The analyst target price is $7.70, representing +722.6% upside from the current price of $0.94.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-230.30%

Beta3.20

50D MA$1.12

200D MA$1.95

Shares out0.03B

Float0.02B

Short ratio—

Avg volume0.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

JSPR vs LLY →JSPR vs JNJ →JSPR vs ABBV →Stock screener →